3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Myeloid
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
17
Myelodysplastic Syndromes
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Hematologic Neoplasms
9
Myeloproliferative Disorders
8
Multiple Myeloma
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Leukemia, Lymphocytic, Chronic, B-Cell
8
Hodgkin Disease
7
Lymphoma, Non-Hodgkin
6
Graft vs Host Disease
6
Waldenstrom Macroglobulinemia
5
Lymphoma
5
Burkitt Lymphoma
5
Recurrence
4
Primary Myelofibrosis
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasms
4
Lymphoma, Mantle-Cell
4
Leukemia, Prolymphocytic
4
Leukemia, Myelomonocytic, Chronic
4
Skin Neoplasms
3
Sarcoma
3
Rhabdomyosarcoma
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Biphenotypic, Acute
3
Leukemia
3
Bronchiolitis Obliterans Syndrome
3
Interventions
Cyclophosphamide
15
Temozolomide
11
Vincristine
10
Magnetic Resonance Spectroscopy
10
Cisplatin
10
Specimen Handling
8
Radiotherapy
8
Etoposide
8
X-Rays
6
Phantoms, Imaging
6
Carboplatin
6
Nuclear Medicine Department, Hospital
5
Lomustine
5
Radiation
4
Platinum
4
Methotrexate
4
Irinotecan
4
Filgrastim
4
Biopsy
4
1,2-diaminocyclohexaneplatinum II citrate
4
etoposide phosphate
3
Thiotepa
3
Nivolumab
3
Granulocyte Colony-Stimulating Factor
3
Celecoxib
3
Bevacizumab
3
Automobiles
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Medulloblastoma
×
Sirolimus
×
1 year
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled